The first institutional-grade operating system for the life settlement market
"The LiqueFex DNA System is designed to be to the life settlement market what the CUSIP is to the public securities market — a foundational identification and data standard intended to make institutional-scale trading possible."
The LiqueFex DNA System is designed to provide a unique identification standard for every life settlement asset — the CUSIP equivalent this market has never had. The identifier methodology itself is prototyped; the persistent, real-time data schema and living data history it's designed to support, accumulating structured information across the full lifecycle of each asset, is still being built. All downstream functions — valuation, compliance, settlement, clearing — are designed to draw directly from the DNA System once that layer is complete.
LiqueFex OS is designed to produce settlement instruments structured for acceptance into existing custodial infrastructure, linked directly to the DNA System. These vehicles are intended to bring life settlement transactions into the settlement infrastructure institutional participants already use — replacing the manual, fragmented settlement processes that have historically excluded institutional capital from this market. This component is in design; custodial acceptance has not yet been established with any institution, and LiqueFi does not custody assets.
LiqueFex OS is designed so that compliance is embedded at the protocol level — not overlaid as a post-process. The architecture is intended to govern every transaction and asset interaction through compliance logic built in from the start, so that non-compliant transactions cannot be constructed and every interaction produces an audit record by default. This enforcement logic is in early development and is not yet part of the operating system's current build.
LiqueFex OS is designed for settlement to occur bilaterally between participants against trust-held assets, with counterparty exposure managed structurally rather than through a central clearinghouse. Because the asset would sit in trust and the carrier would recognise the trust as owner, a transfer is designed to move beneficial interest rather than the policy itself — so settlement capacity is intended to scale with market participation instead of being constrained by centralised infrastructure. This settlement model is still in design. Risk allocation, the point at which finality attaches, and the identity of the compliance obligor will be defined per transaction and set out in full in the briefing materials once implemented.
Artificial intelligence and blockchain are designed to be embedded at the infrastructure level of LiqueFex OS — not retrofitted to existing processes — if and when they are built. AI functions are planned to operate across valuation inputs, risk modelling, and data enrichment; blockchain is planned to provide the immutable record layer across the OS. Both are designed to be chain-agnostic and cross-platform, enabling integration with institutional systems already operating in these environments. This component is under evaluation: no AI or blockchain implementation exists yet, and it is not part of the operating system's current build.
LiqueFex DNA System — the identification layer
Every life settlement policy assigned a DNA System identifier is designed to accumulate a structured, real-time data history — medical, actuarial, custodial, and transactional records attached to a single, permanent reference. The identifier methodology is prototyped; the persistent registry behind it is still in development.
The DNA System is designed to be to the life settlement market what the CUSIP is to the public securities market — a foundational identification and data standard intended to make institutional-scale trading possible. As with the CUSIP, the standard is not meant to price the asset: participants would price against it. All downstream functions — valuation, compliance, settlement, clearing — are designed to draw directly from this layer once it's built.
What the OS is designed to deliver
A unique-identifier methodology, prototyped; the persistent, cross-participant registry is in development.
A live data schema for systematic, institutional-grade mark-to-market — in design, not yet built on real valuation inputs.
Compliance at protocol level — structural, not overlaid — is the design goal. Enforcement logic and audit-trail-by-default are in early development.
Settlement instruments designed for acceptance into existing custodial infrastructure — not yet accepted by any custodian.
Bilateral settlement against trust-held assets, designed to scale horizontally with market volume — architecture in design, not yet implemented.
Designed for infrastructure-level embedding, not retrofitting, cross-platform by design. Under evaluation — no implementation exists yet.
A five-step operating sequence
How a transaction moves through the OS. The sequence below describes the architecture as designed.
Every policy enters the OS through the DNA System, receiving a unique, persistent identifier — the foundational reference for all downstream operations.
Medical, actuarial, custodial, and transactional data streams attach to the DNA record in real time, building a living data history for the asset.
Protocol-level compliance logic governs every interaction — creating an immutable audit trail without manual oversight or post-process verification.
Settlement instruments structured for acceptance into existing custodial infrastructure are issued, linking directly to the DNA record.
Settlement occurs bilaterally against trust-held assets rather than through a central counterparty, scaling capacity horizontally with market participation.
What LiqueFex does not do
Infrastructure is defined as much by what it leaves to others as by what it provides. These are the lines LiqueFi does not cross.
- We do not price policies. Participants value assets using their own models.
- We do not originate, broker, or take principal positions.
- We do not replace your chain, your custodian, or your analytics.
- We do not hold client assets. Trusts do; custodians custody.
We don't tell you what it's worth. We make it possible for you to know — and to prove what you knew, when.
This content is for informational purposes only and does not constitute investment advice, a securities offering, or a solicitation to buy or sell any financial instrument. All inquiries should be directed to info@liquefi.life.
This website contains forward-looking statements regarding market opportunities and platform capabilities. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially. Past performance is not indicative of future results.